Jonathan Anker, MD, PhD

Clinical Focus

• Bladder Cancer
• Genitourinary Malignancies
• Germ Cell Tumors
• Kidney Cancer
• Prostate Cancer
• Renal Cancer
• Testicular Tumors

• Bladder Cancer
• Genitourinary Malignancies
• Germ Cell Tumors
• Kidney Cancer
• Prostate Cancer
• Renal Cancer
• Testicular Tumors

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, New York, NY, 10029

212-241-6756

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial. Mansi Saxena, Jonathan F. Anker, Julia Kodysh, Timothy O’Donnell, Anna M. Kaminska, Marcia Meseck, Olivia Hapanowicz, Scot Anthony Niglio, Andres M. Salazar, Hardik R. Shah, Yayoi Kinoshita, Rachel Brody, Alex Rubinsteyn, Robert P. Sebra, Nina Bhardwaj, Matthew D. Galsky. Nature Cancer
• Characterization of Exceptional Responses in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabozantinib and Immune Checkpoint Inhibitors. Teja Ganta, Jonathan F. Anker, Eric Miller, Himanshu Joshi, Che Kai Tsao, William K. Oh. Clinical Genitourinary Cancer
• Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer. Matthew D. Galsky, Mark Kockx, Juliette Roels, Roos Van Elzen, Xiangnan Guan, Kobe Yuen, Deepali Rishipathak, Jonathan F. Anker, Sacha Gnjatic, Sudeh Izadmehr, Shomyseh Sanjabi, Robert J. Johnston, Maureen Peterson, Hartmut Koeppen, Justin M. David, Saurabh Gupta, Aristotelis Bamias, Jose Angel Arranz, Eiji Kikuchi, Maria De Santis, Ian D. Davis, Patrick Williams, Sandrine Bernhard, Ira Mellman, Enrique Grande, Romain Banchereau, Sanjeev Mariathasan. Cancer Immunology Research

Industry Relationships